Loss of Parkin in mice led to an increased incidence of colitis-associated cancer with elevated inflammation induced by DSS, and treatment with GSK′872, a RIPK3 inhibitor, reversed the effect of Parkin deficiency. The gene discussed is PRKN; the disease is colitis.